The import value of Heparin for therapeutic use to Argentina exhibited fluctuations from 2013 to 2023. Starting from $12.368 million in 2013 and peaking at $15.166 million in 2014, the import values generally trended downward. By 2023, the import value stood at approximately $8.0773 million. The year-on-year variation revealed a significant drop in 2015 (-23.55%) and continuous minor declines in subsequent years, with the most recent reduction of -1.18% in 2023. The compound annual growth rate (CAGR) over the past five years registered a slight decrease of -0.29%.
Looking forward, the forecast suggests a continued decline in import values, with the CAGR for 2024 to 2028 projected at -0.96%. Specific forecasted values indicate a gradual reduction from $8.0173 million in 2024 to $7.6386 million in 2028, which reflects a 4.72% overall drop in this period.
Future trends to watch for:
- Regulatory changes in Argentina’s pharmaceutical import sector.
- Shift in domestic production capabilities and local manufacturing incentives.
- Global market price fluctuations for Heparin and its raw materials.
- Potential changes in medical demand and healthcare policies post-2024.
